Table of Contents 1 Valvular Heart Disease Treatment Market Overview 1.1 Product Overview and Scope of Valvular Heart Disease Treatment 1.2 Classification of Valvular Heart Disease Treatment by Types 1.2.1 Global Valvular Heart Disease Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Valvular Heart Disease Treatment Revenue Market Share by Types in 2018 1.2.3 Cardiac Catheterization 1.2.4 Electrocardiogram (ECG) 1.2.5 Chest X-Ray 1.2.6 Stress Test 1.2.7 Others 1.3 Global Valvular Heart Disease Treatment Market by Application 1.3.1 Global Valvular Heart Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospital & Clinics 1.3.3 Ambulatory Surgical Centers 1.3.4 Research Institutes 1.4 Global Valvular Heart Disease Treatment Market by Regions 1.4.1 Global Valvular Heart Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Valvular Heart Disease Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Valvular Heart Disease Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Valvular Heart Disease Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Valvular Heart Disease Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Valvular Heart Disease Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Valvular Heart Disease Treatment (2014-2024) 2 Company Profiles 2.1 LivaNova PLC 2.1.1 Business Overview 2.1.2 Valvular Heart Disease Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Neovasc Inc. 2.2.1 Business Overview 2.2.2 Valvular Heart Disease Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Medtronic 2.3.1 Business Overview 2.3.2 Valvular Heart Disease Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 B. Braun Melsungen AG 2.4.1 Business Overview 2.4.2 Valvular Heart Disease Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Abbott Laboratories 2.5.1 Business Overview 2.5.2 Valvular Heart Disease Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 Boston Scientific Corp. 2.6.1 Business Overview 2.6.2 Valvular Heart Disease Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 Symetis SA 2.7.1 Business Overview 2.7.2 Valvular Heart Disease Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.8 Edwards Lifesciences Corporation 2.8.1 Business Overview 2.8.2 Valvular Heart Disease Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.9 CryoLife Inc. 2.9.1 Business Overview 2.9.2 Valvular Heart Disease Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.10 Micro Interventional Devices 2.10.1 Business Overview 2.10.2 Valvular Heart Disease Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.11 Braile Biomédica 2.11.1 Business Overview 2.11.2 Valvular Heart Disease Treatment Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Braile Biomédica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.12 Jenavalve Technology 2.12.1 Business Overview 2.12.2 Valvular Heart Disease Treatment Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.13 Lepu Medical Technology Co. 2.13.1 Business Overview 2.13.2 Valvular Heart Disease Treatment Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.14 TTK Healthcare Limited 2.14.1 Business Overview 2.14.2 Valvular Heart Disease Treatment Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.15 Colibri Heart Valve 2.15.1 Business Overview 2.15.2 Valvular Heart Disease Treatment Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Valvular Heart Disease Treatment Market Competition, by Players 3.1 Global Valvular Heart Disease Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Valvular Heart Disease Treatment Players Market Share 3.2.2 Top 10 Valvular Heart Disease Treatment Players Market Share 3.3 Market Competition Trend 4 Global Valvular Heart Disease Treatment Market Size by Regions 4.1 Global Valvular Heart Disease Treatment Revenue and Market Share by Regions 4.2 North America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 5 North America Valvular Heart Disease Treatment Revenue by Countries 5.1 North America Valvular Heart Disease Treatment Revenue by Countries (2014-2019) 5.2 USA Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 6 Europe Valvular Heart Disease Treatment Revenue by Countries 6.1 Europe Valvular Heart Disease Treatment Revenue by Countries (2014-2019) 6.2 Germany Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 6.4 France Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Valvular Heart Disease Treatment Revenue by Countries 7.1 Asia-Pacific Valvular Heart Disease Treatment Revenue by Countries (2014-2019) 7.2 China Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 7.5 India Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 8 South America Valvular Heart Disease Treatment Revenue by Countries 8.1 South America Valvular Heart Disease Treatment Revenue by Countries (2014-2019) 8.2 Brazil Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Valvular Heart Disease Treatment by Countries 9.1 Middle East and Africa Valvular Heart Disease Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) 10 Global Valvular Heart Disease Treatment Market Segment by Type 10.1 Global Valvular Heart Disease Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Valvular Heart Disease Treatment Market Forecast by Type (2019-2024) 10.3 Cardiac Catheterization Revenue Growth Rate (2014-2024) 10.4 Electrocardiogram (ECG) Revenue Growth Rate (2014-2024) 10.5 Chest X-Ray Revenue Growth Rate (2014-2024) 10.6 Stress Test Revenue Growth Rate (2014-2024) 10.7 Others Revenue Growth Rate (2014-2024) 11 Global Valvular Heart Disease Treatment Market Segment by Application 11.1 Global Valvular Heart Disease Treatment Revenue Market Share by Application (2014-2019) 11.2 Valvular Heart Disease Treatment Market Forecast by Application (2019-2024) 11.3 Hospital & Clinics Revenue Growth (2014-2019) 11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019) 11.5 Research Institutes Revenue Growth (2014-2019) 12 Global Valvular Heart Disease Treatment Market Size Forecast (2019-2024) 12.1 Global Valvular Heart Disease Treatment Market Size Forecast (2019-2024) 12.2 Global Valvular Heart Disease Treatment Market Forecast by Regions (2019-2024) 12.3 North America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) 12.6 South America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Valvular Heart Disease Treatment Picture Table Product Specifications of Valvular Heart Disease Treatment Table Global Valvular Heart Disease Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Valvular Heart Disease Treatment Revenue Market Share by Types in 2018 Figure Cardiac Catheterization Picture Figure Electrocardiogram (ECG) Picture Figure Chest X-Ray Picture Figure Stress Test Picture Figure Others Picture Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Application (2014-2024) Figure Valvular Heart Disease Treatment Revenue Market Share by Applications in 2018 Figure Hospital & Clinics Picture Figure Ambulatory Surgical Centers Picture Figure Research Institutes Picture Table Global Market Valvular Heart Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table LivaNova PLC Basic Information, Manufacturing Base and Competitors Table LivaNova PLC Valvular Heart Disease Treatment Type and Applications Table LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Neovasc Inc. Basic Information, Manufacturing Base and Competitors Table Neovasc Inc. Valvular Heart Disease Treatment Type and Applications Table Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Medtronic Basic Information, Manufacturing Base and Competitors Table Medtronic Valvular Heart Disease Treatment Type and Applications Table Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors Table B. Braun Melsungen AG Valvular Heart Disease Treatment Type and Applications Table B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Valvular Heart Disease Treatment Type and Applications Table Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Boston Scientific Corp. Basic Information, Manufacturing Base and Competitors Table Boston Scientific Corp. Valvular Heart Disease Treatment Type and Applications Table Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Symetis SA Basic Information, Manufacturing Base and Competitors Table Symetis SA Valvular Heart Disease Treatment Type and Applications Table Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Edwards Lifesciences Corporation Basic Information, Manufacturing Base and Competitors Table Edwards Lifesciences Corporation Valvular Heart Disease Treatment Type and Applications Table Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table CryoLife Inc. Basic Information, Manufacturing Base and Competitors Table CryoLife Inc. Valvular Heart Disease Treatment Type and Applications Table CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Micro Interventional Devices Basic Information, Manufacturing Base and Competitors Table Micro Interventional Devices Valvular Heart Disease Treatment Type and Applications Table Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Braile Biomédica Basic Information, Manufacturing Base and Competitors Table Braile Biomédica Valvular Heart Disease Treatment Type and Applications Table Braile Biomédica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Jenavalve Technology Basic Information, Manufacturing Base and Competitors Table Jenavalve Technology Valvular Heart Disease Treatment Type and Applications Table Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Lepu Medical Technology Co. Basic Information, Manufacturing Base and Competitors Table Lepu Medical Technology Co. Valvular Heart Disease Treatment Type and Applications Table Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table TTK Healthcare Limited Basic Information, Manufacturing Base and Competitors Table TTK Healthcare Limited Valvular Heart Disease Treatment Type and Applications Table TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Colibri Heart Valve Basic Information, Manufacturing Base and Competitors Table Colibri Heart Valve Valvular Heart Disease Treatment Type and Applications Table Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Players (2014-2019) Table Global Valvular Heart Disease Treatment Revenue Share by Players (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Share by Players in 2017 Figure Global Valvular Heart Disease Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Valvular Heart Disease Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Valvular Heart Disease Treatment Revenue Market Share in 2018 Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Valvular Heart Disease Treatment Revenue Market Share by Regions (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Market Share by Regions (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Market Share by Regions in 2018 Figure North America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Europe Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure South America Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table North America Valvular Heart Disease Treatment Revenue by Countries (2014-2019) Table North America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure North America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure North America Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018 Figure USA Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Canada Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table Europe Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018 Figure Germany Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure UK Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure France Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Russia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Italy Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018 Figure China Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Japan Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Korea Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure India Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table South America Valvular Heart Disease Treatment Revenue by Countries (2014-2019) Table South America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure South America Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure South America Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018 Figure Brazil Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Valvular Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure UAE Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Valvular Heart Disease Treatment Revenue and Growth Rate (2014-2019) Table Global Valvular Heart Disease Treatment Revenue (Million USD) by Type (2014-2019) Table Global Valvular Heart Disease Treatment Revenue Share by Type (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Share by Type (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Share by Type in 2018 Table Global Valvular Heart Disease Treatment Revenue Forecast by Type (2019-2024) Figure Global Valvular Heart Disease Treatment Market Share Forecast by Type (2019-2024) Figure Global Cardiac Catheterization Revenue Growth Rate (2014-2019) Figure Global Electrocardiogram (ECG) Revenue Growth Rate (2014-2019) Figure Global Chest X-Ray Revenue Growth Rate (2014-2019) Figure Global Stress Test Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Table Global Valvular Heart Disease Treatment Revenue by Application (2014-2019) Table Global Valvular Heart Disease Treatment Revenue Share by Application (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Share by Application (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue Share by Application in 2018 Table Global Valvular Heart Disease Treatment Revenue Forecast by Application (2019-2024) Figure Global Valvular Heart Disease Treatment Market Share Forecast by Application (2019-2024) Figure Global Hospital & Clinics Revenue Growth Rate (2014-2019) Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019) Figure Global Research Institutes Revenue Growth Rate (2014-2019) Figure Global Valvular Heart Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Valvular Heart Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Valvular Heart Disease Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) Figure Europe Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) Figure South America Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Valvular Heart Disease Treatment Revenue Market Forecast (2019-2024)

LivaNova PLC Neovasc Inc. Medtronic B. Braun Melsungen AG Abbott Laboratories Boston Scientific Corp. Symetis SA Edwards Lifesciences Corporation CryoLife Inc. Micro Interventional Devices Braile Biomédica Jenavalve Technology Lepu Medical Technology Co. TTK Healthcare Limited Colibri Heart Valve